The self-expanding covered stents market is witnessing significant growth as healthcare providers increasingly focus on advanced vascular intervention technologies to address complex cardiovascular and peripheral vascular conditions. The global self-expanding covered stents market size was estimated at USD 743.8 million in 2025 and is projected to reach USD 1,091.7 million by 2033, growing at a CAGR of 5.0% from 2026 to 2033. The market is benefiting from the growing burden of peripheral artery disease, aortoiliac occlusive disease, and aneurysm-related complications, which continue to create substantial demand for effective treatment solutions. As healthcare systems emphasize improved patient outcomes and reduced procedural risks, self-expanding covered stents are becoming an increasingly preferred option in vascular care.

The adoption of self-expanding covered stents is also being supported by the increasing demand for minimally invasive vascular interventions. These devices offer physicians enhanced flexibility and performance in treating challenging vascular lesions while helping to reduce recovery times and improve procedural efficiency. The section below outlines the key factors driving the growth of the self-expanding covered stents (SX-CS) market, highlighting the rising prevalence of peripheral artery disease and aortoiliac occlusive disease, along with the increasing demand for minimally invasive vascular interventions. Continuous advancements in vascular technologies and expanding clinical applications are further contributing to the market's positive outlook through the forecast period.

Download a free sample copy of the Self-expanding Covered Stents market report to understand detailed coverage and inclusions in the final report

Key Market Trends & Insights

Regional analysis indicates that North America dominated the self-expanding covered stents market in 2025 with a revenue share of 42.8%. The region's leadership is supported by advanced healthcare infrastructure, growing awareness regarding vascular diseases, and the widespread availability of innovative treatment technologies. Strong adoption of minimally invasive procedures and increasing investments in cardiovascular care continue to strengthen the market position of North America.
Within the regional landscape, the self-expanding covered stents industry in the U.S. dominated with a global revenue share of 80.5% in 2025. The country's leadership is attributed to high healthcare spending, a strong presence of medical device manufacturers, and increasing utilization of advanced vascular intervention procedures. Continuous technological innovation and favorable clinical adoption trends further contribute to the growth of the market in the United States.
Based on anatomy, the superficial femoral artery (SFA) segment accounted for the largest revenue share of 44.8% in 2025. The widespread occurrence of vascular conditions affecting the superficial femoral artery and the growing use of stent-based interventions for treatment are contributing factors behind the segment's dominant position. The effectiveness of self-expanding covered stents in managing complex lesions within the SFA segment continues to support demand.
By indication, the aneurysm repair segment accounted for the largest revenue share of 38.2% in 2025. The increasing incidence of aneurysms and the growing preference for minimally invasive repair procedures are driving segment growth. Healthcare professionals continue to utilize self-expanding covered stents for aneurysm management due to their ability to provide effective vascular support and improved treatment outcomes.
By end-use, the hospitals segment led the industry, accounting for the largest revenue share of 57.0% in 2025. Hospitals remain the primary centers for vascular interventions due to their advanced medical infrastructure, availability of specialized healthcare professionals, and ability to manage complex cardiovascular procedures. Rising patient volumes and increasing adoption of advanced vascular treatment technologies further support segment growth.

Looking for more specific insights? Customize this report to suite your business needs

Key Companies & Market Share Insights

Key players operating in the self-expanding covered stents market are undertaking various initiatives to strengthen their presence and increase the reach of their products and services. Strategies such as expansion activities and partnerships are key in propelling market growth. These initiatives are expected to support innovation, enhance product accessibility, and create new opportunities across both developed and emerging healthcare markets throughout the forecast period.

Key Self-expanding Covered Stents Companies:

W. L. Gore & Associates, Inc.
Solaris Endovascular
BD (Angiomed GmbH & Co. Medizintechnik KG)
LeMaitre Vascular, Inc.
Endologix LLC
Artivion, Inc
Merit Medical Systems

Grand View Research offers

Focused market intelligence reports on specific geographies or high-growth segments.
Extended forecast timelines for long-term planning.
Competitor Benchmarking and Supply Chain Analysis
Inclusion of regulatory and policy assessments.
Inclusion of custom data models, KPIs, or applications unique to your business
Specific high-impact Data Decks and Tables to support effective decision making
And much more…

Looking for a report customized to your requirements? Explore our Custom Research Offering

Hospitals Drive Revenue Expansion in Self-Expanding Covered Stents

The global self-expanding covered stents market size was estimated at USD 743.8 million in 2025 and is projected to reach USD 1,091.7 million by 2033